Hartmut Ehrlich: CEO of Abivax

Portrait of Hartmut Ehrlich

Hartmut Ehrlich,  CEO of Abivax, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Abivax is working to develop treatments modulating the body’s natural immune system to treat patients with chronic inflammatory diseases, viral infections and cancer.

Bioasis Technologies

One in Six

Notable employee working in the lab.
Notable

Delivering the Right Drug to the Right Patient

Danbury Hospital Annual Report Cover
Danbury Hospital

A Prescription for the Future